Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Data Byte

The growing landscape of solid tumor CAR T cell targets

CAR T cells against at least 19 targets are in the clinic for solid tumors

March 30, 2022 8:56 PM UTC

The early clinical pipeline of CAR T cell therapies for solid tumors is growing, and it’s no longer concentrated around a small number of solid tumor-selective targets. 

According to BioCentury’s BCIQ database, there are CAR T cell candidates against at least 19 different targets in development for solid tumors. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article